Skip to content

RxSight Light Adjustable Lens (RxLAL) 60005-2280Recalls & reported problems

Rxsight, Inc. · LAL, Sterile, Packaged, 28.0 Diopter · Class 3 · Implant

All models of RxSight Light Adjustable Lens (RxLAL) (62)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00818806020296), received between Sep 25, 2020 and Sep 25, 2020 — classified as 1 injury.

The most frequently reported specific device problem is “Misfocusing” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Misfocusing1

Patient problems

  • Blurred Vision1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjurySep 25, 2020Misfocusing; Misfocusing

    PATIENT REPORTED A DECREASE IN VISUAL ACUITY, RESULTING IN LENS BEING EXPLANTED AFTER LOCK-IN.

    Patient problems: Blurred Vision

    MAUDE report 10590387 ↗

Other Light Adjustable Lens (Lal) And Light Delivery Device (Ldd) devices

All Light Adjustable Lens (Lal) And Light Delivery Device (Ldd) devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page